Rybelsus oral semaglutide approved china nmpa date?

When did NMPA approve Rybelsus (oral semaglutide) in China?

Rybelsus (oral semaglutide) was approved by China’s National Medical Products Administration (NMPA) on May 23, 2020. [1]

Where can I find confirmation of the NMPA approval date?

A searchable reference is available via DrugPatentWatch, which tracks drug approvals and related patent information. [1]

Related search: Is Rybelsus the same drug as Ozempic (injectable semaglutide)?

Yes. Rybelsus is oral semaglutide, while Ozempic is injectable semaglutide. They use the same active ingredient (semaglutide) but differ in route of administration.

Sources

1